The Ducest neurostimulator offers new treatment options for chronic pain disorders such as back pain and severe circulatory disorders in the legs (PAD - peripheral arterial occlusive disease)

Jena, 20.06.2024 - The medical technology pioneer biolitec, previously known primarily for its minimally invasive laser technologies, is now offering an innovative therapy for pain reduction in the form of the new Ducest neurostimulator.

The Ducest neurostimulator was developed by Ducest Medical GmbH, a biolitec Group company. The effectiveness of neurostimulation in chronic pain disorders is now considered proven. The Department of Neurosurgery at the Medical University of Innsbruck considers neurostimulative procedures to be a valuable therapy in cases where pain patients no longer respond to any of the drug treatment options.1 The Ducest neurostimulator is approved for the treatment of chronic pain disorders and circulatory disorders in the legs (peripheral arterial disease - PAD). In both cases, the Ducest neurostimulator opens up new, natural treatment options that are gentle on the patient. The effectiveness of the Ducest neurostimulator for chronic back pain and PAD has been proven by a study carried out at Vienna General Hospital by Prof. Sabine Sator-Katzenschlager2 et. al. and a study carried out in the Department of Surgery at Wiener Neustadt Regional Hospital by Dr. Thomas Payrits3 et. al. For the duration of the therapy, the doctor places the small neurostimulator in the patient's shoulder area without interfering with the patient's daily activities.

In industrialized countries, 3 out of 10 people, and even 4 out of 10 older people, suffer from chronic pain. Circulatory diseases can also lead to chronic pain. In Germany, one in five people over the age of 65 is affected by PAD, i.e. chronically painful legs when walking as a result of circulatory disorders, which can lead to amputation. One in five Germans is also affected by chronic back pain. In Ducest neurostimulation therapy for PAD, a stimulation needle is attached to the ear, which emits regular current pulses over a longer period of time. The impulses cause modulations in the brain stem via an afferent nerve pathway that transmits signals to the brain. This has a positive effect on blood circulation in the extremities, including the legs, so that patients can usually walk longer distances again. This significantly improves quality of life - largely without side effects. In chronic pain disorders, the Ducest neurostimulator improves the interaction between the brain stem and periphery, which supports the healing of inflammatory pain triggers. Pain is often significantly reduced after just two to three days - without medication.

The Ducest neurostimulator increases the chances of PAD patients being able to walk longer distances and reduces the subjective perception of pain in chronic pain disorders, such as back pain. You can find more information at: https://www.biolitec.de/produkte/ducest-neurostimulator-v.html.

1 Eisner, Wilhelm: Neurostimulation for the treatment of chronic pain; Schmerz Nachrichten No. 2, May 2020, Springer-Verlag, p. 32(https://www.pains.at/wp-content/uploads/Schmerz-220-DFP-Eisner-Neurostimulation.pdf)
2 Sator-Katzenschlager, Sabine et. al: The Short- and Long-Term Benefit in Chronic Low Back Pain Through Adjuvant Electrical Versus Manual Auricular Acupuncture; Anesth Analg No. 98, 2004, Lippincott Williams & Wilkins, pp. 1359-64(https://aurimod.com/site/assets/files/1223/sator-katzenschlager_et_al_2004.pdf)
3 Payrits, Thomas: Vagal stimulation - a new option for the conservative treatment of peripheral arterial occlusive disease; Zentralbl Chir 2011 No. 136, Georg Thieme Verlag KG, pp. 431-435 (https://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0031-1283739.pdf)